Non-surgical Periodontal Treatment on Hemogram, Lipid and Glycemic Profiles in Patients With Coronariopathies
Primary Purpose
Periodontitis, Coronariopathy
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Periodontal treatment
Sponsored by

About this trial
This is an interventional treatment trial for Periodontitis focused on measuring periodontal diseases, cardiovascular diseases, periodontitis treatment
Eligibility Criteria
Inclusion Criteria:
- Undergoing cardiovascular treatment;
- Eight viable teeth in the oral cavity;
- Four periodontal sites with periodontal probing depths ≥5mm in different teeth.
Exclusion Criteria:
-
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Periodontal treatment
Control
Arm Description
The test group received oral hygiene instructions, supragingival and subgingival scaling and root planning using curettes and an ultrasonic appliance.
Outcomes
Primary Outcome Measures
Reduction in probing depth in sites with PPD>3mm
Reduction of 11.4% in probing depth in sites with Periodontal Probing Depth>3mm
Reduction in probing depth in sites with PPD>5mm
Reduction of 6.3% in probing depth in sites with Periodontal Probing Depth>5mm
Reduction in probing depth in sites with CAL>3mm
Reduction of 4.6% in probing depth in sites with Clinical Attachment Level >3mm.
Reduction in probing depth in sites with CAL >5mm
Reduction of 3.6% in probing depth in sites with Clinical Attachment Level >5mm.
Leukocyte count
Non-significant reduction of leukocyte count in the test group. Mean difference of 74.6 m/mcL.
Glucose
Glucose showed a non-significant increase in the test group. Mean difference of 24.2 mg/dL.
Hemocyte
Hemocyte presented a non-significant reduction in the test group. Mean difference 0.39 m/mcL
Hemoglobin
Non-significant reduction in test group. Mean difference of 0.2 g/dL
Total Cholesterol
Significant reduction in the test group. Mean reduction of 27.4 mg/dL.
High density lipid
Significant reduction in test group. Mean difference of 8.2 mg/dL.
Low density lipid
Non-significant reduction in test group. Mean difference of 8.9 mg/dL.
Secondary Outcome Measures
Full Information
NCT ID
NCT02150005
First Posted
May 18, 2014
Last Updated
May 25, 2014
Sponsor
Universidade Veiga de Almeida
Collaborators
Rio de Janeiro State Research Supporting Foundation (FAPERJ)
1. Study Identification
Unique Protocol Identification Number
NCT02150005
Brief Title
Non-surgical Periodontal Treatment on Hemogram, Lipid and Glycemic Profiles in Patients With Coronariopathies
Official Title
Effects of Non-surgical Periodontal Treatment on Hemogram, Lipid and Glycemic Profiles of Patients With an Indication for Surgical Coronary Revascularization
Study Type
Interventional
2. Study Status
Record Verification Date
May 2014
Overall Recruitment Status
Completed
Study Start Date
January 2009 (undefined)
Primary Completion Date
December 2010 (Actual)
Study Completion Date
undefined (undefined)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Universidade Veiga de Almeida
Collaborators
Rio de Janeiro State Research Supporting Foundation (FAPERJ)
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Objective: The aim of this study was to examine the effects of non-surgical periodontal treatment on the hemogram, glycemic and lipid profiles in cardiopathic patients with an indication for surgical revascularization.
Materials and Methods: Twenty-two patients with chronic periodontitis, over 35 years of age (mean age 59.45 years) randomly assigned into 2 groups were evaluated. Test group (n=11), received periodontal treatment before the surgical procedure, and control group (n=11), did not received periodontal treatment prior to surgery.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Periodontitis, Coronariopathy
Keywords
periodontal diseases, cardiovascular diseases, periodontitis treatment
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
22 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Periodontal treatment
Arm Type
Experimental
Arm Description
The test group received oral hygiene instructions, supragingival and subgingival scaling and root planning using curettes and an ultrasonic appliance.
Arm Title
Control
Arm Type
No Intervention
Intervention Type
Procedure
Intervention Name(s)
Periodontal treatment
Primary Outcome Measure Information:
Title
Reduction in probing depth in sites with PPD>3mm
Description
Reduction of 11.4% in probing depth in sites with Periodontal Probing Depth>3mm
Time Frame
Baseline and 90 days after the initial exam
Title
Reduction in probing depth in sites with PPD>5mm
Description
Reduction of 6.3% in probing depth in sites with Periodontal Probing Depth>5mm
Time Frame
Baseline and 90 days after the initial exam
Title
Reduction in probing depth in sites with CAL>3mm
Description
Reduction of 4.6% in probing depth in sites with Clinical Attachment Level >3mm.
Time Frame
Baseline and 90 days after the initial exam
Title
Reduction in probing depth in sites with CAL >5mm
Description
Reduction of 3.6% in probing depth in sites with Clinical Attachment Level >5mm.
Time Frame
Baseline and 90 days after the initial exam
Title
Leukocyte count
Description
Non-significant reduction of leukocyte count in the test group. Mean difference of 74.6 m/mcL.
Time Frame
Baseline and 90 days after the initial exam
Title
Glucose
Description
Glucose showed a non-significant increase in the test group. Mean difference of 24.2 mg/dL.
Time Frame
Baseline and 90 days after the initial exam
Title
Hemocyte
Description
Hemocyte presented a non-significant reduction in the test group. Mean difference 0.39 m/mcL
Time Frame
Baseline and 90 days after initial exam
Title
Hemoglobin
Description
Non-significant reduction in test group. Mean difference of 0.2 g/dL
Time Frame
Baseline and 90 days after initial exam
Title
Total Cholesterol
Description
Significant reduction in the test group. Mean reduction of 27.4 mg/dL.
Time Frame
Baseline and 90 days after initial exam
Title
High density lipid
Description
Significant reduction in test group. Mean difference of 8.2 mg/dL.
Time Frame
Baseline and 90 days after initial exam
Title
Low density lipid
Description
Non-significant reduction in test group. Mean difference of 8.9 mg/dL.
Time Frame
Baseline and 90 days after initial exam
10. Eligibility
Sex
All
Minimum Age & Unit of Time
35 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Undergoing cardiovascular treatment;
Eight viable teeth in the oral cavity;
Four periodontal sites with periodontal probing depths ≥5mm in different teeth.
Exclusion Criteria:
-
12. IPD Sharing Statement
Learn more about this trial
Non-surgical Periodontal Treatment on Hemogram, Lipid and Glycemic Profiles in Patients With Coronariopathies
We'll reach out to this number within 24 hrs